Affiliation:
1. Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China
Abstract
Chronic non-specific neck pain (CNNP) poses a substantial health and economic burden in China. This study introduces a gamified motion-sensing health application framework to address the limitations of existing health applications. The gamified cervical spine somatic exercise application employs motion capture technology alongside the smartphone’s built-in sensors to simulate accurate somatic interactions. Controlled experiments and data analyses demonstrated that the application significantly outperformed traditional text and video interventions in relieving participants’ neck pain by increasing their average daily activity and compliance with the cervical spine exercise routine. The neck pain level of the participants is quantified by the Neck Disability Index (NDI). The results from the controlled experiments demonstrate that this gamified approach significantly decreases the Neck Disability Index (NDI) score from 1.54 to 1.24, highlighting its ability to alleviate neck pain and increase user compliance.
Reference54 articles.
1. Preliminary analysis on X-ray in youth neck type of cervical spondylosis with upper crossed syndrome;Ma;China J. Orthop. Traumatol.,2019
2. Gómez, F., Escribá, P., Oliva-Pascual-Vaca, J., Méndez-Sánchez, R., and Puente-González, A.S. (2020). Immediate and Short-term effects of upper cervical high-velocity, low-amplitude manipulation on standing postural control and cervical mobility in chronic nonspecific neck pain: A randomized controlled trial. J. Clin. Med., 9.
3. Global, regional, and national burden of neck pain in the general population, 1990-2017: Systematic analysis of the Global Burden of Disease Study 2017;Safiri;BMJ,2020
4. Report on the Burden of Disease in China and Provincial Administrative Regions, 1990~2016;Zeng;Chin. Circ. J.,2018
5. Global, regional, and national burden of neck pain, 1990–2020, and projections to 2050: A systematic analysis of the Global Burden of Disease Study 2021;Wu;Lancet Rheumatol.,2024